BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg. 1996;83:107-111. [PMID: 8653330 DOI: 10.1002/bjs.1800830134] [Cited by in Crossref: 108] [Cited by in F6Publishing: 93] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Geh J. The use of chemoradiotherapy in oesophageal cancer. European Journal of Cancer 2002;38:300-13. [DOI: 10.1016/s0959-8049(01)00353-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
2 Wang S, Wang S, Liu W, Sun S, Liu X, Ge N, Guo J, Wang G, Feng L. The application of linear endoscopic ultrasound in the patients with esophageal anastomotic strictures. Endosc Ultrasound. 2015;4:126-131. [PMID: 26020047 DOI: 10.4103/2303-9027.156740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Erasmus JJ, Rohren EM, Hustinx R. PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric Cancers. PET Clinics 2008;3:135-45. [DOI: 10.1016/j.cpet.2008.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48:667-670. [PMID: 11302966 DOI: 10.1136/gut.48.5.667] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 5.4] [Reference Citation Analysis]
5 Kato H, Fukuchi M, Miyazaki T, Nakajima M, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Oriuchi N, Endo K, Kuwano H. Positron emission tomography in esophageal cancer. Esophagus 2005;2:111-21. [DOI: 10.1007/s10388-005-0053-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Jingu K, Matsushita H, Takeda K, Umezawa R, Takahashi C, Sugawara T, Kubozono M, Abe K, Tanabe T, Shirata Y, Yamamoto T, Ishikawa Y, Nemoto K. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study. BMC Cancer 2012;12:542. [PMID: 23171077 DOI: 10.1186/1471-2407-12-542] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
7 Pande SS, Purandare N, Puranik A, Shah S, Agrawal A, C S P, Prabhash K, Agarwal JP, Rangarajan V. Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resection. Nucl Med Commun 2020;41:959-64. [PMID: 32796485 DOI: 10.1097/MNM.0000000000001229] [Reference Citation Analysis]
8 Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Miyazawa Y, Shiratori T, Uno T, Itoh H, Ochiai T. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24-31. [PMID: 12563234 DOI: 10.1067/msy.2003.31] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 4.9] [Reference Citation Analysis]
9 Law S, Wong J. Therapeutic options for esophageal cancer. J Gastroenterol Hepatol 2004;19:4-12. [PMID: 14675236 DOI: 10.1111/j.1440-1746.2004.03154.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
10 Czito BG, Palta M, Willett CG. Results of the FFCD 9901 trial in early-stage esophageal carcinoma: is it really about neoadjuvant therapy? J Clin Oncol. 2014;32:2398-2400. [PMID: 24982460 DOI: 10.1200/jco.2014.55.7231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
11 Matsushita H, Jingu K, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N, Katagiri Y, Kadoya N. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review. Technol Cancer Res Treat 2018;17:1533033818803597. [PMID: 30352542 DOI: 10.1177/1533033818803597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
12 Chen F, Sato K, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H. Pulmonary resection for metastasis from esophageal carcinoma. Interact Cardiovasc Thorac Surg. 2008;7:809-812. [PMID: 18556725 DOI: 10.1510/icvts.2008.180778] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
13 Kim TJ, Lee KH, Kim YH, Sung SW, Jheon S, Cho S, Lee KW. Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know. RadioGraphics 2007;27:409-29. [DOI: 10.1148/rg.272065034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
14 Law S, Kwong DL, Wong KH, Kwok KF, Wong J. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 2006;10:1301-11. [PMID: 17114016 DOI: 10.1016/j.gassur.2006.06.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
15 Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238:339-347; discussion 347-348. [PMID: 14501500 DOI: 10.1097/01.sla.0000086545.45918.ee] [Cited by in Crossref: 73] [Cited by in F6Publishing: 88] [Article Influence: 3.8] [Reference Citation Analysis]
16 Zhong D, Zhou Y, Li Y, Wang Y, Zhou W, Cheng Q, Chen L, Zhao J, Li X, Yan X. Intraoperative recurrent laryngeal nerve monitoring: a useful method for patients with esophageal cancer: RLNM for esophageal cancer. Dis Esophagus 2014;27:444-51. [DOI: 10.1111/j.1442-2050.2012.01414.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
17 Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Resectable Esophageal Carcinoma: Local Control with Neoadjuvant Chemotherapy and Radiation Therapy. Radiology 1999;213:67-72. [DOI: 10.1148/radiology.213.1.r99oc1767] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
18 DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12-30. [PMID: 16378161 DOI: 10.1245/aso.2005.12.025] [Cited by in Crossref: 152] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
19 Heise JW, Heep H, Frieling T, Sarbia M, Hartmann KA, Röher HD. Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus. BMC Cancer. 2001;1:20. [PMID: 11737874 DOI: 10.1186/1471-2407-1-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wikman A, Johar A, Lagergren P. Presence of symptom clusters in surgically treated patients with esophageal cancer: Implications for survival: Symptom Clusters and Survival. Cancer 2014;120:286-93. [DOI: 10.1002/cncr.28308] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
21 Yamashita H, Okuma K, Wakui R, Kobayashi-Shibata S, Ohtomo K, Nakagawa K. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis. Radiother Oncol. 2011;98:255-260. [PMID: 21074880 DOI: 10.1016/j.radonc.2010.10.021] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
22 Santeufemia DA, Piredda G, Fadda GM, Rocca PC, Costantino S, Sanna G, Sarobba MG, Pinna MA, Putzu C, Farris A. Successful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapse. World J Gastroenterol 2006; 12(34): 5565-5568 [PMID: 17007002 DOI: 10.3748/wjg.v12.i34.5565] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
23 Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558-565. [PMID: 21327531 DOI: 10.1007/s11605-011-1458-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
24 Bosset JF, Lorchel F, Mantion G. Neoadjuvant treatment of early stage squamous cell carcinoma of the esophagus*. Diseases of the Esophagus 2002;15:117-20. [DOI: 10.1046/j.1442-2050.2002.00213.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98-103. [PMID: 11553217 DOI: 10.1046/j.1442-2050.2001.00164.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
26 Ma GW, Situ DR, Ma QL, Long H, Zhang LJ, Lin P, Rong TH. Three-field vs two-field lymph node dissection for esophageal cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18022-18030 [PMID: 25548502 DOI: 10.3748/wjg.v20.i47.18022] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
27 Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg. 2001;88:338-356. [PMID: 11260097 DOI: 10.1046/j.1365-2168.2001.01670.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 130] [Article Influence: 6.9] [Reference Citation Analysis]
28 Mao YS, Suntharalingam M, Krasna MJ. Management of late distant metastases after trimodality therapy for esophageal cancer. Ann Thorac Surg 2003;76:1742-3. [PMID: 14602333 DOI: 10.1016/s0003-4975(03)00653-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines. Cancers (Basel) 2020;12:E3356. [PMID: 33202734 DOI: 10.3390/cancers12113356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tsurumaru D, Hiraka K, Komori M, Shioyama Y, Morita M, Honda H. Role of barium esophagography in patients with locally advanced esophageal cancer: evaluation of response to neoadjuvant chemoradiotherapy. Radiol Res Pract 2013;2013:502690. [PMID: 24369500 DOI: 10.1155/2013/502690] [Reference Citation Analysis]
31 Chow VL, Chan JY, Law SY. Esophagogastric Preservation in the Surgical Management of Proximal Esophageal Cancer. The Annals of Thoracic Surgery 2019;108:1029-36. [DOI: 10.1016/j.athoracsur.2019.04.060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
32 Wayman J, Bennett MK, Raimes SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer. 2002;86:1223-1229. [PMID: 11953876 DOI: 10.1038/sj.bjc.6600252] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
33 Krughoff K, Schned A, Ren B, Pais VM Jr. Complaint of Testicular Discomfort in Patient with Esophageal Adenocarcinoma. Case Rep Urol 2021;2021:6692578. [PMID: 33986968 DOI: 10.1155/2021/6692578] [Reference Citation Analysis]
34 Law S, Wong J. Esophageal cancer: . Current Opinion in Gastroenterology 2001;17:393-9. [DOI: 10.1097/00001574-200107000-00016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, Mitsuhashi N. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol 2008;15:2451-7. [PMID: 18592318 DOI: 10.1245/s10434-008-0016-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
36 Roedl JB, Harisinghani MG, Colen RR, Fischman AJ, Blake MA, Mathisen DJ, Mueller PR. Assessment of Treatment Response and Recurrence in Esophageal Carcinoma Based on Tumor Length and Standardized Uptake Value on Positron Emission Tomography–Computed Tomography. The Annals of Thoracic Surgery 2008;86:1131-8. [DOI: 10.1016/j.athoracsur.2008.05.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
37 Pham KH, Ramaswamy MR, Hawkins RA. Advances in positron emission tomography imaging for the GI tract. Gastrointestinal Endoscopy 2002;55:S53-63. [DOI: 10.1067/mge.2002.124741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
38 Sharma P, Jain S, Karunanithi S, Pal S, Julka PK, Thulkar S, Malhotra A, Bal C, Kumar R. Diagnostic accuracy of 18F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma. Eur J Nucl Med Mol Imaging 2014;41:1084-92. [DOI: 10.1007/s00259-013-2664-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lambert R. An Overview of the Management of Cancer of the Esophagus. Gastrointestinal Endoscopy Clinics of North America 1998;8:415-34. [DOI: 10.1016/s1052-5157(18)30270-8] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
40 Chowdhury F, Bradley K, Gleeson F. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma. Clinical Radiology 2008;63:1297-309. [DOI: 10.1016/j.crad.2008.05.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
41 Brijbassie A, Shami VM. Esophageal Cancer: Ultrasonography. Gastroenterology Clinics of North America 2009;38:93-104. [DOI: 10.1016/j.gtc.2009.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Ferri LE, Law S, Wong K, Kwok K, Wong J. The Influence of Technical Complications on Postoperative Outcome and Survival After Esophagectomy. Ann Surg Oncol 2006;13:557-64. [DOI: 10.1245/aso.2006.04.040] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
43 Thorban S, Rosenberg R, Busch R, Roder RJ. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 2000;83:35-9. [PMID: 10883665 DOI: 10.1054/bjoc.2000.1199] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
44 Cense HA, van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893-906. [PMID: 16997168 DOI: 10.1016/j.bpg.2006.03.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
45 Kantarci M, Polat P, Alper F, Eroglu A, Eren S, Okur A, Onbaş O. Comparison of CT and MRI for the diagnosis recurrent esophageal carcinoma after operation. Dis Esophagus. 2004;17:32-37. [PMID: 15209738 DOI: 10.1111/j.1442-2050.2004.00354.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
46 Fein M, Fuchs K, Ritter MP, Freys SM, Heimbucher J, Staab C, Thiede A. Application of the new classification for cancer of the cardia. Surgery 1998;124:707-14. [DOI: 10.1067/msy.1998.91363] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
47 Ikeda Y, Tobari S, Niimi M, Kan S, Takami H, Kodaira S. Reliable cervical anastomosis through the retrosternal route with stepwise gastric tube. J Thorac Cardiovasc Surg 2003;125:1306-12. [PMID: 12830049 DOI: 10.1016/s0022-5223(02)73407-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
48 Lertbutsayanukul C, Tharavej C, Klaikeaw N, Prayongrat A, Lowanitchai C, Sriuranpong V. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma. Thorac Cancer 2017;8:219-28. [PMID: 28322515 DOI: 10.1111/1759-7714.12427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
49 Banks KP, Song WS. Role of positron emission tomography-computed tomography in gastrointestinal malignancies. Radiol Clin North Am 2013;51:799-831. [PMID: 24010907 DOI: 10.1016/j.rcl.2013.05.003] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
50 Djärv T, Lagergren P. Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. Eur J Cancer 2011;47:530-5. [PMID: 21074989 DOI: 10.1016/j.ejca.2010.10.014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
51 Amano T, Matsumoto T, Hayashi T, Arakawa A, Sonoue H, Kajiyama Y, Tsurumaru M. Subepithelial extension of squamous cell carcinoma in the esophagus: Histopathological study using D2-40 immunostaining for 108 superficial carcinomas. Pathol Int 2007;57:759-64. [DOI: 10.1111/j.1440-1827.2007.02171.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
52 Law S, Fok M, Chow* S, Chu K, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial. The Journal of Thoracic and Cardiovascular Surgery 1997;114:210-7. [DOI: 10.1016/s0022-5223(97)70147-8] [Cited by in Crossref: 272] [Cited by in F6Publishing: 64] [Article Influence: 10.9] [Reference Citation Analysis]
53 Djärv T, Blazeby JM, Lagergren P. Predictors of postoperative quality of life after esophagectomy for cancer. J Clin Oncol. 2009;27:1963-1968. [PMID: 19289614 DOI: 10.1200/jco.2008.20.5864] [Cited by in Crossref: 79] [Cited by in F6Publishing: 23] [Article Influence: 6.1] [Reference Citation Analysis]
54 Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Kuwano H. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg 2004;91:1004-9. [PMID: 15286962 DOI: 10.1002/bjs.4595] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
55 Thorban S, Rosenberg R, Maak M, Friederichs J, Gertler R, Siewert JR. Impact of disseminated tumor cells in gastrointestinal cancer. Expert Rev Mol Diagn 2006;6:333-43. [PMID: 16706737 DOI: 10.1586/14737159.6.3.333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
56 Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205-211. [PMID: 14759776 DOI: 10.1016/j.jamcollsurg.2003.10.005] [Cited by in Crossref: 209] [Cited by in F6Publishing: 220] [Article Influence: 11.6] [Reference Citation Analysis]
57 Yano M, Takachi K, Doki Y, Miyashiro I, Kishi K, Noura S, Eguchi H, Yamada T, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Matsunaga T, Imaoka S. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 2006;19:73-7. [PMID: 16643173 DOI: 10.1111/j.1442-2050.2006.00543.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
58 Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology. 2005;47:123-131. [PMID: 16045772 DOI: 10.1111/j.1365-2559.2005.02189.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
59 Jennings NA, Griffin SM, Lamb PJ, Preston S, Richardson D, Karat D, Hayes N. Prospective study of bone scintigraphy as a staging investigation for oesophageal carcinoma. Br J Surg 2008;95:840-4. [PMID: 18551472 DOI: 10.1002/bjs.6175] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Li Q, Wu SG, Gao JM, Xu JJ, Hu LY, Xu T. Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes. J Radiat Res. 2013;54:307-314. [PMID: 23124992 DOI: 10.1093/jrr/rrs096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
61 Plaisant N, Senesse P, Azria D, Lemanski C, Ychou M, Quenet F, Saint-aubert B, Rouanet P. Surgery for Esophageal Cancer after Concomitant Radiochemotherapy: Oncologic and Functional Results. World J Surg 2005;29:32-8. [DOI: 10.1007/s00268-004-7455-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
62 Law S, Wong J. The current management of esophageal cancer. Adv Surg 2007;41:93-119. [PMID: 17972559 DOI: 10.1016/j.yasu.2007.05.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
63 Jingu K, Nemoto K, Matsushita H, Takahashi C, Ogawa Y, Sugawara T, Nakata E, Takai Y, Yamada S. Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer. 2006;6:50. [PMID: 16515704 DOI: 10.1186/1471-2407-6-50] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
64 Takemura M, Sakurai K, Takii M, Yoshida K. Metachronous pulmonary metastasis after radical esophagectomy for esophageal cancer: prognosis and outcome. J Cardiothorac Surg. 2012;7:103. [PMID: 23031450 DOI: 10.1186/1749-8090-7-103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
65 Dresner SM, Wayman J, Shenfine J, Harris A, Hayes N, Griffin SM. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362-373. [PMID: 10718968 DOI: 10.1046/j.1365-2168.2000.01541.x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 138] [Article Influence: 7.7] [Reference Citation Analysis]
66 Hiranyatheb P, Osugi H. Radical lymphadenectomy in esophageal cancer: from the past to the present. Dis Esophagus. 2013;Jun 24; Epub ahead of print. [PMID: 23796327 DOI: 10.1111/dote.12091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
67 Haustermans K, Lerut A. Esophageal Tumors. In: Grégoire V, Scalliet P, Ang KK, editors. Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy. Berlin: Springer Berlin Heidelberg; 2004. pp. 107-19. [DOI: 10.1007/978-3-662-06270-8_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Mattioli S, Di Simone MP, Ferruzzi L, D'ovidio F, Pilotti V, Carella R, D'errico A, Grigioni WF. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection *. Diseases of the Esophagus 2001;14:104-9. [DOI: 10.1046/j.1442-2050.2001.00165.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
69 Kemper M, Izbicki JR, Reeh M. Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer? Ann Surg Oncol 2021;28:8020-1. [PMID: 34618248 DOI: 10.1245/s10434-021-10837-x] [Reference Citation Analysis]
70 Shim YM, Kim HK, Kim K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010;5:707-12. [PMID: 20421764 DOI: 10.1097/JTO.0b013e3181d3ccb2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
71 Marjanovic G, Schricker M, Walch A, zur Hausen A, Hopt UT, Imdahl A, Makowiec F. Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer. J Gastrointest Surg. 2011;15:29-37. [PMID: 20976569 DOI: 10.1007/s11605-010-1359-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
72 Lee SJ, Lee KS, Yim YJ, Kim TS, Shim YM, Kim K. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol. 2005;60:547-554. [PMID: 15851041 DOI: 10.1016/j.crad.2004.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
73 Law S, Fok M, Chu KM, Wong J. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg. 1997;226:169-173. [PMID: 9296510 DOI: 10.1097/00000658-199708000-00008] [Cited by in Crossref: 162] [Cited by in F6Publishing: 133] [Article Influence: 6.5] [Reference Citation Analysis]
74 Wang Z, Lin S, Wang F, Liu S. Salvage lymphadenectomy for isolated cervical lymph node recurrence after curative resection of thoracic esophageal squamous cell carcinoma. Ann Transl Med 2019;7:238. [PMID: 31317008 DOI: 10.21037/atm.2019.04.64] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters M, De Leyn P, Van Raemdonck D, Mortelmans L. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg. 2000;120:1085-1092. [PMID: 11088030 DOI: 10.1067/mtc.2000.110464] [Cited by in Crossref: 126] [Cited by in F6Publishing: 89] [Article Influence: 6.0] [Reference Citation Analysis]
76 Waraich N, Rashid F, Jan A, Semararo D, Deb R, Leeder P, Iftikhar S. Vascular invasion is not a risk factor in oesophageal cancer recurrence. International Journal of Surgery 2011;9:237-40. [DOI: 10.1016/j.ijsu.2010.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
77 Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases. Oncol Lett. 2013;5:185-190. [PMID: 23255917 DOI: 10.3892/ol.2012.1007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
78 Law S, Wong J. Lymph node dissection in surgical treatment of esophageal neoplasms. Surg Oncol Clin N Am 2007;16:115-31. [PMID: 17336240 DOI: 10.1016/j.soc.2006.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
79 Harewood GC, Kumar KS. Assessment of clinical impact of endoscopic ultrasound on esophageal cancer. J Gastroenterol Hepatol. 2004;19:433-439. [PMID: 15012782 DOI: 10.1111/j.1440-1746.2003.03304.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
80 Vazquez–sequeiros E, Wang L, Burgart L, Harmsen W, Zinsmeister A, Allen M, Jondal M, Wiersema M. Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 2002;122:1815-21. [DOI: 10.1053/gast.2002.33665] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
81 Joseph R, Laks S, Meyers M, McRee AJ. Multidisciplinary Approach to the Management of Esophageal Malignancies. World J Surg 2017;41:1726-33. [PMID: 28361298 DOI: 10.1007/s00268-017-4009-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
82 Gemici C, Yaprak G, Batirel HF, Ilhan M, Mayadagli A. Radiation field size and dose determine oncologic outcome in esophageal cancer. World J Surg Oncol 2016;14:263. [PMID: 27737673 DOI: 10.1186/s12957-016-1024-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
83 Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006;78:236-44. [PMID: 16545878 DOI: 10.1016/j.radonc.2006.01.009] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 7.8] [Reference Citation Analysis]
84 Wu X, Hedman H, Bergqvist M, Bergström S, Henriksson R, Gullbo J, Lennartsson J, Hesselius P, Ekman S. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncologica 2011;51:69-76. [DOI: 10.3109/0284186x.2011.562239] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
85 Hsu PK, Wang BY, Chou TY, Huang CS, Wu YC, Hsu WH. The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy. J Surg Oncol 2011;103:416-20. [PMID: 21400526 DOI: 10.1002/jso.21850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
86 Kano M, Shimada Y, Kaganoi J, Sakurai T, Li Z, Sato F, Watanabe G, Imamura M. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 2000;82:429-35. [PMID: 10646900 DOI: 10.1054/bjoc.1999.0938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
87 Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, Jager PL, Van Eck-Smit BL, Plukker JT, van Lanschot JJ. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review. Radiology. 2005;236:841-851. [PMID: 16118165 DOI: 10.1148/radiol.2363041042] [Cited by in Crossref: 207] [Cited by in F6Publishing: 175] [Article Influence: 12.2] [Reference Citation Analysis]
88 Baba Y, Watanabe M, Kawanaka K, Iwagami S, Ishimoto T, Iwatsuki M, Yoshida N, Yamashita Y, Baba H. Radiofrequency ablation for pulmonary metastases from esophageal squamous cell carcinoma. Dis Esophagus 2014;27:36-41. [PMID: 23384275 DOI: 10.1111/dote.12034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
89 Thomson IG, Smithers BM, Gotley DC, Martin I, Thomas JM, O'Rourke P, Barbour AP. Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence. Ann Surg 2010;252:281-91. [PMID: 20647926 DOI: 10.1097/SLA.0b013e3181e909a2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
90 Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791-800. [PMID: 15492560 DOI: 10.1097/01.sla.0000143123.24556.1c] [Cited by in Crossref: 273] [Cited by in F6Publishing: 242] [Article Influence: 15.2] [Reference Citation Analysis]
91 Zhang WW, Zhu YJ, Yang H, Wang QX, Wang XH, Xiao WW, Li QQ, Liu MZ, Hu YH. Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma. Sci Rep 2015;5:8071. [PMID: 25627119 DOI: 10.1038/srep08071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
92 Tong DK, Kwong DL, Law S, Wong KH, Wong J. Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease. J Gastrointest Surg 2008;12:1638-45; discussion 1645. [PMID: 18704592 DOI: 10.1007/s11605-008-0654-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
93 Bonavina L, Soligo D, Quirici N, Bossolasco P, Cesana B, Lembertenghi Deliliers G, Peracchia A. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery. 2001;129:15-22. [PMID: 11150029 DOI: 10.1067/msy.2001.109503] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
94 Theologou T, Diab M, Kyaw PA, Gosney JR, Mcshane J, Howes N, Page RD, Shackcloth M. The impact of positive circumferential margin on survival following oesophagectomy using the new 7th TNM classification†. European Journal of Cardio-Thoracic Surgery 2013;44:855-9. [DOI: 10.1093/ejcts/ezt164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
95 Iitaka D, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, Murayama Y, Ikoma H, Kuriu Y, Nakanishi M, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E. Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case. Surg Today 2013;43:556-61. [PMID: 22752641 DOI: 10.1007/s00595-012-0240-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
96 Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: A review of the evidence. Cancer 2004;101:657-70. [DOI: 10.1002/cncr.20443] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]